玻璃体内注射技术规范——2018年欧洲视网膜专家学会共识解读

玻璃体内注射（intravitreal injections，IVI）已成为眼科最常用的治疗手段之一，能够提高许多药物在眼部治疗的效果，减少全身不良反应，是目前最有效的治疗各种视网膜和脉络膜疾病的方法。为了IVI规范化管理操作及提高安全性，欧洲视网膜专家学会于2018年发布了规范化IVI技术共识。本文将对此共识进行解读，以帮助我国眼科医生提高对此技术的理解，减少不良反应。

Consensus interpretation on the specification of vitreous injection technology by the European society of retinal experts in 2018

Intravitreal injection （IVI） has become one of the most commonly used treatment methods in ophthalmology，which can improve the effect of many drugs in the eye treatment and reduce the adverse reactions of the whole body.In order to standardize the management of IVI operations and improve security，the European academy of retinal experts issued the consensus on standardized vitreous injection technology in 2018，which will be interpreted in this paper to help Chinese oculists improve their understanding of this technology and reduce adverse reactions.